Aegerion Pharmaceuticals Inc. (AEGR) slipped more than 16 percent to $36.80 in after ... In the first-quarter ended March 31, 2014, non-GAAP net loss, which excludes stock-based compensation, narrowed to $7.3 million or $0.25 per share …
He also is on the Board of Directors of Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Amicus Therapeutics, Inc. (NASDAQ: FOLD). Dr. Barer holds a B.S. from Brooklyn College. …
Aegerion Pharmaceuticals, Inc. AEGR announced that it has entered into a definitive ... Post completion, each outstanding share of Aegerion’s common stock will be exchanged for 1.0256 shares of QLT’s common stock. QLT will change its …
The GT10B turbine, with a capacity of 34,100 shp (shaft horse power), will be used for gas compression, driving a Mitsubishi compressor at the AEGR (Algerian Edjeleh Gas ... London and New York stock exchanges. GE Power …
On Nasdaq, Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) was setting the pace, up 44% at $1.92, as it agreed to be taken over by QLT Inc (NASDAQ:QLTI, TSE:QLT). Upon completion of the proposed merger, each outstanding share of …
Oak Hill Advisors sold $18 million in Cooper-Standard Holdings's (PINK:COSH) stock on the open market. This time last year, it was a purchaser of the automotive system and component manufacturer. At InsiderInsights.com, we find new …
Aegerion Pharmaceuticals, Inc. AEGR reported a loss of 46 cents per share in the second ... $27.8 million mainly due to lower salary and employee-related costs, and lower stock-based compensation related to a reduction in headcount in …
Among the companies with shares expected to actively trade in Monday’s session are Sony Corp. (SNE, 6758.TO), Aegerion Pharmaceuticals Inc. (AEGR), AT&T Inc. (T), Groupon Inc. (GRPN) and Toyota Motor Corp. (TM, 7203.TO). …
Aegerion Pharmaceuticals surged +9.82% today, ending the day priced at $25.04. The biotech stock is a new third quarter acquisition for billionaire investor George Soros. Its price has declined -21.55% over the past three months. Orbitz …
Aegerion Pharmaceuticals, Inc.’s (AEGR) Juxtapid was approved in Canada as an adjunct ... We expect investor focus to remain on the HoFH drug going forward. Aegerion, a biopharma stock, currently carries a Zacks Rank #4 (Sell). Some …